# SkinHealth Systems Inc. > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/en/companies/SkinHealth Systems Inc.). ## Overview SkinHealth Systems Inc. is a U.S.-based medical aesthetics company that designs, manufactures, and sells skin-health treatment systems and related consumables. Its portfolio centers on Hydrafacial delivery systems and proprietary treatment solutions, with additional offerings in microneedling and scalp-health treatments sold through a global network of providers. ## Products & services • Hydrafacial delivery systems and treatment platforms • Proprietary consumables, serums, and single-use tips • SkinStylus nano-channeling and microneedling systems • HydraScalp powered by Keravive scalp treatments • Provider training, marketing, and support services - **Delivery Systems** (29%) — Capital equipment used by providers to perform Hydrafacial treatments. - **Consumables** (71%) — Recurring-use tips, solutions, and serums consumed during treatments. - Hydrafacial delivery systems and treatment platforms - Proprietary consumables, serums, and single-use tips - SkinStylus nano-channeling and microneedling systems - HydraScalp powered by Keravive scalp treatments - Provider training, marketing, and support services ## Customers The company sells primarily to licensed providers in the professional medical and aesthetic channels, including dermatologists, plastic surgeons, medical spas, estheticians, and beauty retailers. These customers buy the systems to offer in-office skin treatments and buy consumables repeatedly as treatment volume grows. The business also reaches spas, hotels, and other retailers that use the platform to broaden service offerings. - **Professional medical providers** (primary) — Dermatologists, plastic surgeons, and medical practices buy systems and consumables to offer in-office aesthetic treatments. - **Medical spas and estheticians** (primary) — These providers use the devices to deliver branded skin treatments and expand service menus. - **Beauty retail and hospitality channels** (secondary) — Spas, hotels, and retailers buy treatments and equipment to add premium skin-health services. - Dermatologists and plastic surgeons buying clinical treatment systems - Medical spas purchasing devices and recurring consumables - Estheticians using the platform for skin-health services - Spas, hotels, and retailers offering branded treatments - Providers buy consumables repeatedly as treatment volume rises ## Geography The company operates globally, with direct sales in some countries and distributor or hybrid models in others. Management disclosed that markets outside the United States and Canada represented about 35% of net sales in fiscal 2025, showing a meaningful international footprint. China is now served through a distributor partner rather than direct sales, which changes how the company reaches that market. - United States and Canada are the core commercial base - About 35% of net sales came from outside the U.S. and Canada - Direct sales in some countries, distributor models in others - China is served through a distributor partner - Global provider network supports international treatment adoption ## Strategy The company is focused on expanding its installed base of delivery systems and increasing utilization so consumables become a larger share of revenue. It is also investing in brand building, provider education, digital marketing, and commercial analytics to strengthen demand and retention across its platform. Product innovation in Hydrafacial, SkinStylus, and HydraScalp remains central to broadening the treatment portfolio and supporting provider economics. - **Grow the installed base and utilization** (medium-term) — More active systems create a larger recurring consumables stream and deepen provider dependence on the platform. - **Expand consumer demand generation** (short-term) — Consumer pull helps providers fill appointments and increases treatment frequency. - **Broaden the product portfolio** (medium-term) — Additional treatment categories can increase wallet share within provider practices. - Expand installed base of delivery systems worldwide - Increase utilization to drive recurring consumables sales - Strengthen brand awareness and provider education - Improve digital marketing and AI-assisted online engagement - Broaden the platform with SkinStylus and HydraScalp ## Risks The business faces intense competition in a fragmented beauty and medical aesthetics market, where pricing, brand strength, and product innovation can shift quickly. It is also exposed to regulatory scrutiny over product claims, adverse events, and recalls, plus supply-chain, tariff, and foreign-exchange pressures tied to its global footprint. Because consumables depend on installed-base utilization, any slowdown in provider adoption or treatment volume can weaken recurring demand. - **Competitive pressure in beauty health and medical aesthetics** [high] — The market is fragmented and rivals offer similar devices and treatments at aggressive prices. - **Regulatory and claims substantiation risk** [high] — FDA, FTC, and foreign regulators can challenge marketing claims or product classifications. - **Product safety and recall risk** [high] — Adverse events or device defects can trigger reporting obligations, recalls, and reputational damage. - **International and supply-chain exposure** [medium] — Global sourcing and distribution create exposure to tariffs, logistics disruptions, and currency moves. - Intense competition from similar skin-treatment brands and devices - Regulatory risk around product claims, safety, and marketing substantiation - Adverse events or recalls could damage reputation and sales - Tariffs, supply-chain disruptions, and FX swings affect costs and demand - Consumables growth depends on installed-base utilization and provider activity ## Accounting Revenue is recognized when control transfers, generally at shipment, which makes timing sensitive to order patterns and channel mix. The company also relies on estimates for trade-in programs, refurbished device resale values, inventory obsolescence, and impairment testing for goodwill and intangibles. Deferred tax asset valuation allowances and uncertain tax positions are important because cumulative losses can limit the use of future tax benefits. - **Revenue recognition timing** — Quarterly comparability and reported growth rates - **Trade-in and refurbished device estimates** — Revenue, inventory carrying value, and gross profit - **Goodwill and intangible impairment** — Potential non-cash impairment charges - **Deferred tax asset valuation allowance** — Income tax expense and net deferred tax assets - Revenue recognized at shipment for systems and consumables - Trade-in program estimates affect revenue and inventory values - Inventory write-downs can arise on refurbished or obsolete devices - Goodwill and intangibles require annual impairment testing - Deferred tax asset valuation allowance depends on future taxable income --- *Last updated: 2026-06-16T23:10:00.831677+00:00*